Karyopharm Therapeutics Inc. Stock Forecast
Big movements in Karyopharm Therapeutics Inc. stock price on Thursday moving 16.39% between high and low
(Updated on Apr 18, 2024)
The Karyopharm Therapeutics Inc. stock price fell by -7.25% on the last day (Thursday, 18th Apr 2024) from $1.38 to $1.28. During the last trading day the stock fluctuated 16.39% from a day low at $1.22 to a day high of $1.42. The price has fallen in 7 of the last 10 days and is down by -3.76% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -2 million shares and in total, 1 million shares were bought and sold for approximately $1.67 million.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 25.17% during the next 3 months and, with a 90% probability hold a price between $1.37 and $2.48 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
KPTI Signals & Forecast
There are mixed signals in the stock today. The Karyopharm Therapeutics Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $1.36. On a fall, the stock will find some support from the short-term average at $1.25. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Tuesday, February 06, 2024, and so far it has fallen -22.89%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Karyopharm Therapeutics Inc. stock
On the downside, the stock finds support just below today's level from accumulated volume at $1.21 and $1.16. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Karyopharm Therapeutics Inc. finds support just below today's level at $1.21. If this is broken, then the next support from accumulated volume will be at $1.16 and $1.04.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.200 between high and low, or 16.39%. For the last week, the stock has had daily average volatility of 14.88%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (KPTI) For The Upcoming Trading Day Of Friday 19th
For the upcoming trading day on Friday, 19th we expect Karyopharm Therapeutics Inc. to open at $1.31, and during the day (based on 14 day Average True Range), to move between $1.13 and $1.43, which gives a possible trading interval of +/-$0.151 (+/-11.77%) up or down from last closing price. If Karyopharm Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 23.54% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $1.34 (4.69%) than the support at $1.21 (5.47%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Karyopharm Therapeutics Inc. stock A Buy?
Karyopharm Therapeutics Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.
Current score: -4.634 Sell Candidate Downgraded
Predicted Opening Price for Karyopharm Therapeutics Inc. of Friday, April 19, 2024
| Fair opening price April 19, 2024 | Current price |
|---|---|
| $1.31 ( 2.08%) | $1.28 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for KPTI
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1.51 | 17.71 % | |
| R2 | 1.43 | 11.74 % | ||
| R1 | 1.38 | 8.05 % | ||
| Current price: | 1.28 | |||
| Support | S1 | 1.23 | -3.89 % | |
| S2 | 1.18 | -7.57 % | ||
| S3 | 1.11 | -13.54 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1.51 | 17.97 % | |
| R2 | 1.35 | 5.47 % | ||
| R1 | 1.34 | 4.69 % | ||
| Current price | 1.28 | |||
| Support | S1 | 1.21 | -5.47% | |
| S2 | 1.16 | -9.38% | ||
| S3 | 1.04 | -18.75% |
FAQ
Click here for our free guide on how to buy Karyopharm Therapeutics Inc. Stock.
